French expert opinion on the long-term management of relapsing multiple sclerosis with cladribine tablets beyond year 4.

Ricigliano VAG, Ciron J, Bourre B, Guennoc A M, Castelnovo G, Deschamps J, Payet M, Clavelou P, Vermersch P, de Seze J, et al.